SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K Current Report was filed on December 2, 2024, by National Health Investors Inc, a Maryland corporation. The filing addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is strictly focused on personnel and governance matters.
Material Changes
- Director Appointment: The Board appointed Candice W. Todd to fill the seat vacated by the retirement of Mr. W. Andrew Adams, effective January 1, 2025.
- Director Retirement: Mr. W. Andrew Adams is retiring from the Board effective December 31, 2024, as previously announced on November 5, 2024.
- Committee Assignments: Ms. Todd has not been appointed to any Board committees at this time.
Guidance, Outlook, and Management Commentary
The filing includes no financial guidance, outlook, or management commentary regarding business operations. The appointment follows a search initiated in May 2024 by the Nominating and Corporate Governance Committee. Ms. Todd will be submitted to stockholders for election at the 2025 annual meeting. Her compensation will align with the Company's standard arrangements for non-employee directors as detailed in the 2024 proxy statement.
Key Facts for Investor Verification
- Verify the effective date of Ms. Todd's appointment (January 1, 2025) and her status as a nominee for the 2025 annual meeting.
- Review the 2024 Proxy Statement (Schedule 14A) filed on April 4, 2024, for details on director compensation.
- Confirm Ms. Todd's background as a former Global CFO of Morgan Stanley Real Estate Investments and current director of Highwoods Properties, Inc.
- Note that no related-party transactions or special arrangements exist between Ms. Todd and the Company.